Friday, September 11, 2009

Medical News

Medical News


Dual antiplatelet therapy best for low TE risk patients after stenting

Posted: 10 Sep 2009 05:00 PM PDT

Oral anticoagulant therapy regimens in percutaneous coronary intervention and stent implantation patients should be tailored to their risk for thromboembolism, researchers suggest.

Microbubbles show promise as adjunct to sonothrombolysis

Posted: 10 Sep 2009 05:00 PM PDT

The use of microbubbles to accelerate ultrasound-enhanced sonothrombolysis in acute stroke leads to improved recanalization rates compared with thrombolysis alone but also ups the risk for hemorrhagic transformation, preliminary data suggest.

Responses to facial expressions of disgust diminished in psoriasis patients

Posted: 10 Sep 2009 05:00 PM PDT

Patients with psoriasis appear to develop coping mechanisms to protect them from stressful emotional responses elicited by people's facial expressions of disgust, study findings show.

Protein expression linked to prostate cancer castration resistance

Posted: 10 Sep 2009 05:00 PM PDT

Androgen ablation increases class III beta-tubulin expression in prostate cancer, which is associated with progression to the castration-resistant state, increasing the risk for mortality, say French and US scientists.

Tau expression does not predict paclitaxel response

Posted: 10 Sep 2009 05:00 PM PDT

Expression of microtubule-associated protein Tau messenger RNA in pretreatment cancer biopsies is not clinically useful to select or exclude breast cancer patients for adjuvant paclitaxel chemotherapy, researchers report.

Protein expression linked to prostate cancer castration resistance

Posted: 10 Sep 2009 05:00 PM PDT

Androgen ablation increases class III beta-tubulin expression in prostate cancer, which is associated with progression to the castration-resistant state, increasing the risk for mortality, say French and US scientists.

Greatest CVD risk reduction with low LDL and high HDL cholesterol

Posted: 10 Sep 2009 05:00 PM PDT

US researchers report that lovastatin therapy produces the greatest reduction in acute major coronary events for patients when low-density lipoprotein cholesterol is substantially reduced and high-density lipoprotein cholesterol is increased by at least 7.5%.

Low thigh circumference increases risk for death and heart disease

Posted: 10 Sep 2009 05:00 PM PDT

Men and women with a thigh circumference below 60 cm have an increased risk for heart disease or premature death compared with those with larger thighs, report researchers.

Culturally adapted intervention improves weight loss in Native Americans with Type 2 diabetes

Posted: 10 Sep 2009 05:00 PM PDT

A culturally adapted nutritional intervention known as the "Medicine Wheel Model for Nutrition" shows promise for improving weight loss in Native Americans with Type 2 diabetes.

HbA1c associated with subclinical CVD in nondiabetic populations

Posted: 10 Sep 2009 05:00 PM PDT

Glycated hemoglobin levels in the nondiabetic range are associated with some measures of subclinical cardiovascular disease, report researchers in the journal Diabetes Care.

Comparative amiodarone, dronedarone benefits in AF remain uncertain

Posted: 10 Sep 2009 05:00 PM PDT

Indirect comparative meta-analysis results indicate that amiodarone is more effective than dronedarone for maintenance of sinus rhythm in patients with atrial fibrillation, but is associated with more adverse effects.

European CRT survey reveals widespread off-label CRT use

Posted: 10 Sep 2009 05:00 PM PDT

Results of a Europe-wide survey suggest that clinicians are exploring wider indications for cardiac resynchronization therapy in their patients than are currently fully supported by the evidence from clinical trials.

Tau expression does not predict paclitaxel response

Posted: 10 Sep 2009 05:00 PM PDT

Expression of microtubule-associated protein Tau messenger RNA in pretreatment cancer biopsies is not clinically useful to select or exclude breast cancer patients for adjuvant paclitaxel chemotherapy, researchers report.

No comments:

Post a Comment